Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Change in Accured Expenses (2016 - 2025)

Intellia Therapeutics (NTLA) has disclosed Change in Accured Expenses for 11 consecutive years, with $9.0 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 128.36% to $9.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.3 million through Dec 2025, up 49.23% year-over-year, with the annual reading at -$5.3 million for FY2025, 49.23% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $9.0 million at Intellia Therapeutics, up from -$715000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $18.4 million in Q4 2021, with the low at -$22.4 million in Q1 2024.
  • Average Change in Accured Expenses over 5 years is $1.2 million, with a median of $3.0 million recorded in 2022.
  • Peak annual rise in Change in Accured Expenses hit 552.33% in 2021, while the deepest fall reached 2692.09% in 2021.
  • Over 5 years, Change in Accured Expenses stood at $18.4 million in 2021, then crashed by 83.33% to $3.1 million in 2022, then skyrocketed by 194.01% to $9.0 million in 2023, then tumbled by 56.23% to $4.0 million in 2024, then skyrocketed by 128.36% to $9.0 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $9.0 million, -$715000.0, and $832000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.